Review



ranger sfa  (Hemoteq AG)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Hemoteq AG ranger sfa
    Ranger Sfa, supplied by Hemoteq AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ranger+sfa/ranger+sfa/pm29730375-12-0-5
    Average 90 stars, based on 1 article reviews
    ranger sfa - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Comparison:

    Article Title: Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
    Article Snippet: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: RANGER SFA was sponsored by Hemoteq AG, Würselen, Germany (a member of the Freudenberg Medical group).

    Article Title: 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
    Article Snippet: RANGER SFA was sponsored by Hemoteq (a member of the Freudenberg Medical oup).



    Similar Products

    ranger ii sfa  (Boston Scientific Corporation)
    90
    Boston Scientific Corporation ranger ii sfa
    <t>RANGER</t> II <t>superficial</t> <t>femoral</t> <t>artery</t> <t>(SFA)</t> long lesion patient cohort. The pooled long lesion cohort comprises patients from the RANGER II SFA RCT and long balloon sub-study who were treated with the DCB and who had a lesion length ⩾ 100 mm. DCB, drug-coated balloon; PTA, percutaneous transluminal angioplasty; RCT, randomized controlled trial.
    Ranger Ii Sfa, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ranger+sfa/ranger+ii+sfa/pmc09551318-209-1-7
    Average 90 stars, based on 1 article reviews
    ranger ii sfa - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    ranger ii sfa trial  (Boston Scientific Corporation)
    90
    Boston Scientific Corporation ranger ii sfa trial
    <t>RANGER</t> II <t>superficial</t> <t>femoral</t> <t>artery</t> <t>(SFA)</t> long lesion patient cohort. The pooled long lesion cohort comprises patients from the RANGER II SFA RCT and long balloon sub-study who were treated with the DCB and who had a lesion length ⩾ 100 mm. DCB, drug-coated balloon; PTA, percutaneous transluminal angioplasty; RCT, randomized controlled trial.
    Ranger Ii Sfa Trial, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ranger+sfa/ranger+ii+sfa+trial/pm34016410-204-1-8
    Average 90 stars, based on 1 article reviews
    ranger ii sfa trial - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    ranger sfa  (Hemoteq AG)
    90
    Hemoteq AG ranger sfa
    <t>RANGER</t> II <t>superficial</t> <t>femoral</t> <t>artery</t> <t>(SFA)</t> long lesion patient cohort. The pooled long lesion cohort comprises patients from the RANGER II SFA RCT and long balloon sub-study who were treated with the DCB and who had a lesion length ⩾ 100 mm. DCB, drug-coated balloon; PTA, percutaneous transluminal angioplasty; RCT, randomized controlled trial.
    Ranger Sfa, supplied by Hemoteq AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ranger+sfa/ranger+sfa/pm29730375-12-0-5
    Average 90 stars, based on 1 article reviews
    ranger sfa - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    ranger sfa paclitaxel-coated balloon  (Lutonix Inc)
    90
    Lutonix Inc ranger sfa paclitaxel-coated balloon
    <t>RANGER</t> II <t>superficial</t> <t>femoral</t> <t>artery</t> <t>(SFA)</t> long lesion patient cohort. The pooled long lesion cohort comprises patients from the RANGER II SFA RCT and long balloon sub-study who were treated with the DCB and who had a lesion length ⩾ 100 mm. DCB, drug-coated balloon; PTA, percutaneous transluminal angioplasty; RCT, randomized controlled trial.
    Ranger Sfa Paclitaxel Coated Balloon, supplied by Lutonix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ranger+sfa/ranger+sfa+paclitaxel+coated+balloon/pm29730375-168-9-21
    Average 90 stars, based on 1 article reviews
    ranger sfa paclitaxel-coated balloon - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    RANGER II superficial femoral artery (SFA) long lesion patient cohort. The pooled long lesion cohort comprises patients from the RANGER II SFA RCT and long balloon sub-study who were treated with the DCB and who had a lesion length ⩾ 100 mm. DCB, drug-coated balloon; PTA, percutaneous transluminal angioplasty; RCT, randomized controlled trial.

    Journal: Vascular Medicine (London, England)

    Article Title: The RANGER II superficial femoral artery trial: 1-year results of the long lesion cohort

    doi: 10.1177/1358863X221097164

    Figure Lengend Snippet: RANGER II superficial femoral artery (SFA) long lesion patient cohort. The pooled long lesion cohort comprises patients from the RANGER II SFA RCT and long balloon sub-study who were treated with the DCB and who had a lesion length ⩾ 100 mm. DCB, drug-coated balloon; PTA, percutaneous transluminal angioplasty; RCT, randomized controlled trial.

    Article Snippet: Funding: RANGER II SFA was funded by Boston Scientific Corporation, Marlborough, MA, USA.

    Techniques:

    Lesion lengths in pivotal DCB trials , – and studies of ‘long’ lesions. , , , Reported mean lesion length (SD) and minimum and maximum lengths per study eligibility criteria shown. The COMPARE study stratified enrollment by lesion length and included 276 patients with lesions > 10 cm. Maximum lesion length for both the RANGER II SFA RCT and long balloon sub-study contributing to the long lesion cohort was 180 mm. *DCB group shown. DCB, drug-coated balloon; SFA, superficial femoral artery; RCT, randomized controlled trial.

    Journal: Vascular Medicine (London, England)

    Article Title: The RANGER II superficial femoral artery trial: 1-year results of the long lesion cohort

    doi: 10.1177/1358863X221097164

    Figure Lengend Snippet: Lesion lengths in pivotal DCB trials , – and studies of ‘long’ lesions. , , , Reported mean lesion length (SD) and minimum and maximum lengths per study eligibility criteria shown. The COMPARE study stratified enrollment by lesion length and included 276 patients with lesions > 10 cm. Maximum lesion length for both the RANGER II SFA RCT and long balloon sub-study contributing to the long lesion cohort was 180 mm. *DCB group shown. DCB, drug-coated balloon; SFA, superficial femoral artery; RCT, randomized controlled trial.

    Article Snippet: Funding: RANGER II SFA was funded by Boston Scientific Corporation, Marlborough, MA, USA.

    Techniques: